Welcome to our dedicated page for Bleichroeder Acquisition II-A SEC filings (Ticker: BBCQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bleichroeder Acquisition II-A's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bleichroeder Acquisition II-A's regulatory disclosures and financial reporting.
Bleichroeder Acquisition Corp. II and Pasqal announced that Pasqal has secured expected total funding of at least €340 million, comprising a €170 million private financing round and an approximately €170 million (USD200 million) committed convertible financing in connection with their planned business combination announced on March 4, 2026. The communication states this financing is the first step toward Pasqal’s intended dual listing on Nasdaq and Euronext Paris and says the company will use the capital to scale production, expand R&D, and strengthen global deployment.
The notice explains that a registration statement on Form F-4 will be filed and that shareholders will receive a definitive proxy/prospectus after effectiveness; it cautions that the planned combination and financing are subject to customary approvals and risks.
Bleichroeder Acquisition Corp. II announced a proposed Business Combination to merge with Pasqal Holding SAS. The agreement values the combined company at $2 billion pre-money, includes a $200 million convertible financing and up to $289 million of additional proceeds dependent on investor redemptions. The transaction assigns a pro forma market capitalization of approximately $2.6 billion and is expected to close in the second half of the year. The merger will be submitted to Bleichroeder shareholders and Bleichroeder intends to file a Registration Statement on Form F-4; consummation is subject to shareholder and regulatory approvals.
Bleichroeder Acquisition Corp. II disclosed a March 4, 2026 LinkedIn communication from Pasqal Holding SAS about their proposed business combination and related financing and corporate plans.
Pasqal described accelerated commercialization, geographic expansion across Europe, Asia Pacific, North America and the Middle East, and stated an initial NASDAQ listing expected in 2026. The communication includes standard forward-looking statements and notes that a Form F-4 registration statement and definitive proxy/prospectus will be filed; shareholder approval and regulatory conditions apply, including that consummation is subject to required regulatory approvals.
Bleichroeder Acquisition Corp. director Philippe Nyssen filed an initial ownership report stating that he does not beneficially own any of the company’s securities. The Form 3 confirms his status as a director and clarifies that, as of the event date, no shares or derivative securities are reported as held.
Bleichroeder Acquisition Corp. director Clemence Rasigni filed an initial ownership report stating that no securities of the company are beneficially owned. This Form 3 identifies Rasigni as a director of Bleichroeder Acquisition Corp. with zero non-derivative or derivative holdings as of the reported event date.
Bleichroeder Acquisition Corp. II filed an 8-K announcing that its Board appointed Philippe Nyssen and Clemence Rasigni as directors, effective immediately. Both are classified as independent directors, with Nyssen joining the Board’s audit committee.
Nyssen, age 37, brings mergers and acquisitions and growth investing experience from IronPine Sarl and Sofina, while Rasigni, age 52, has over two decades in equity capital markets, including senior roles at Merrill Lynch. The company states there are no family relationships or related-party transactions requiring disclosure and that each new director entered joinder and indemnification agreements similar to those of existing officers and directors.